Nathan Steven D
Transaction: 06/04/2026
BUY
Change
+115,000
Price
$0.18
Filing
06/05/2026
Type
BUY
Gossamer Bio, Inc.
GOSS • Biotechnology
$0.18
▼ -0.00 (-0.17%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$41.04M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 2.64Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 18, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.18
Change-0.17%
Shares Out234.14M
Market Cap$41.04M
Enterprise Value$141.55M
52W Range0.14 - 3.87
Beta2.01
P/E-0.23
P/S0.74
P/B-0.25
P/FCF-0.24
EV/Sales2.55
Price$0.18
Change-0.17%
Shares Out234.14M
Market Cap$41.04M
Enterprise Value$141.55M
52W Range0.14 - 3.87
Beta2.01
P/E-0.23
P/S0.74
P/B-0.25
P/FCF-0.24
EV/Sales2.55
EV/EBITDA-0.83
EV/FCF-0.83
Earnings Yield-439.52%
FCF Yield-414.96%
Dividend Yield0.00%
Gross Margin97.93%
Oper. Margin-3.37%
Profit Margin-3.51%
Debt/Eq-1.65
Current Ratio2.64
Quick Ratio2.64
Target$3.47
Target Upside1879.46%
Target Median$3.00
Target Range0.30 - 9.00
Volume11.30M
Avg Volume11.93M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
28
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 2.64Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 17 analyst votes · 2026-09-05
74/100
Bullish
Bullish
10
Hold
5
Bearish
2
Price Target
2026-07-02
Low
$0.30
Mean
$0.77
Median
$1.00
High
$1.00
Insider Transactions
Recent executive and insider activity
⚠ 4 high-volume insider sells detected
Milligan Sandra
Transaction: 06/04/2026
BUY
Change
+115,000
Price
$0.18
Filing
06/05/2026
Type
BUY
Cox Russell J.
Transaction: 06/04/2026
BUY
Change
+115,000
Price
$0.18
Filing
06/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Nathan Steven D | BUY | +115,000 | $0.18 | 06/04/2026 | 06/05/2026 |
| Milligan Sandra | BUY | +115,000 | $0.18 | 06/04/2026 | 06/05/2026 |
| Cox Russell J. | BUY | +115,000 | $0.18 | 06/04/2026 | 06/05/2026 |
| Daniel Thomas O | BUY | +115,000 | $0.18 | 06/04/2026 | 06/05/2026 |
| Drynan Skye | BUY | +115,000 | $0.18 | 06/04/2026 | 06/05/2026 |
| Quisel John D | BUY | +115,000 | $0.18 | 06/04/2026 | 06/05/2026 |
| Christian Waage | SELL | -70,000 | $1.36 | 03/19/2026 | 03/20/2026 |
| Giraudo Bryan | SELL | -211,500 | $2.16 | 03/19/2026 | 03/20/2026 |
| Hasnain Faheem | SELL | -47,000 | $12.10 | 03/19/2026 | 03/20/2026 |
| Smith Robert Paul JR | SELL | -562,500 | $2.88 | 03/19/2026 | 03/20/2026 |
| Peterson Caryn | SELL | -125,000 | $0.84 | 03/19/2026 | 03/20/2026 |
| Aranda Richard | SELL | -157,500 | $2.16 | 03/19/2026 | 03/20/2026 |
| Christian Waage | BUY | +506,250 | $2.88 | 01/02/2026 | 01/05/2026 |
| Christian Waage | BUY | +84,500 | Not reported | 01/02/2026 | 01/05/2026 |
| Peterson Caryn | BUY | +84,500 | Not reported | 01/02/2026 | 01/05/2026 |
| Peterson Caryn | BUY | +506,250 | $2.88 | 01/02/2026 | 01/05/2026 |
| Aranda Richard | BUY | +93,750 | Not reported | 01/02/2026 | 01/05/2026 |
| Aranda Richard | BUY | +562,500 | $2.88 | 01/02/2026 | 01/05/2026 |
| Smith Robert Paul JR | BUY | +93,750 | Not reported | 01/02/2026 | 01/05/2026 |
| Smith Robert Paul JR | BUY | +562,500 | $2.88 | 01/02/2026 | 01/05/2026 |